Jan 12, 2026 · The Wegovy pill is now available nationwide. Here, a weight loss expert explains how the oral GLP-1 works, efficacy vs. injections, and what it costs.

Dec 18, 2025 · Discover frequently asked and common questions about Orforglipron, an oral GLP-1 medication that is in development for type 2 diabetes and obesity by Eli Lilly and Company.

Dec 23, 2025 · The FDA approves Wegovy, the first oral GLP-1 pill, offering a new weight loss solution for those struggling with obesity and overweight.

Dec 23, 2025 · The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk announced the approval of its oral Wegovy pill, an oral …

Dec 22, 2025 · Novo Nordisk said the starting dose of 1.5 milligrams will be available in early January in pharmacies and via select telehealth providers with savings offers for $149 per month. The approval...

Oct 6, 2025 · The U.S. Food and Drug Administration approved the first GLP-1 drug for type 2 diabetes in 2005 and another, the first for weight loss, in 2014. New iterations have been rolling out ever since.

Nov 5, 2025 · This article compares oral and injectable GLP-1 treatments in terms of effectiveness, side effects, convenience, and cost, and examines new therapies in the pipeline expected to shape …

Jan 8, 2026 · With this full oral GLP-1 drug list and guide, learn how GLP-1 pills (Wegovy pill, Rybelsus, orforglipron) work, results, side effects, and more.

Jan 7, 2026 · Glucagon-like peptide-1 (GLP-1) injections like Wegovy (semaglutide) and Zepbound (tirzepatide) have revolutionized the weight-loss medication market. Now, oral GLP-1 pills are …

Nov 20, 2025 · The new medication, a daily oral GLP-1 pill called orforglipron, which can promote weight loss in adults with obesity, demonstrates additional potential for adults who have both obesity and …